Who founded Rhizome AI?

Rhizome AI was founded by Chetan Mishra in 2025.

Who are Rhizome AI's investors?

Rhizome AI's investors include Y Combinator.

How much funding has Rhizome AI raised?

Rhizome AI has disclosed $85K raised across 1 of its 2 known rounds.

Where is Rhizome AI headquartered?

Rhizome AI is headquartered in New York City, US.

Rhizome AI

YC W26

New York City, US · Founded 2025 · Delaware corporation · 1 employees · Hiring · 1 known investors

Rhizome AI provides an AI research platform that answers regulatory and clinical questions by citing documents from health authority databases across multiple markets, with built-in hallucination prevention. The product serves pharmaceutical companies, consultants, and researchers who need to understand regulatory positions and guidance from FDA, EMA, and other regional authorities.

AI & Machine Learning Enterprise Software HealthtechUnited States of AmericaAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (W26)

Rhizome AI was founded in 2025 by Chetan Mishra.

Chetan Mishra inFounderChetan Mishra is a software engineer who previously worked at Instabase where he closed enterprise deals, and has experience with vector databases and machine learning research in the life sciences domain.

Investors · 1

Y CombinatorSan Francisco · $500K

Funding

SEC filings, press & company announcements

$85K disclosed across 1 of 2 rounds · 2025

Undisclosed amountPre-SeedApr 2025
Source ↗

▶$85KraisedJan 2026 · 2 investors · Computers

Rule 506(c)

Officers, directors & promoters on the filing

Chetan MishraExecutive Officer

Offering amount: $85K
Amount sold: $85K
Minimum investment: $85K
First sale: Nov 2025
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Images

Competitors · 1

by search overlap

Greenlight Guru31 shared keywordsGreenlight Guru provides quality management, product development, and clinical evidence software built specifically for medical device companies. Its platform helps medtech teams manage compliance, design controls, risk, and clinical data collection across the product lifecycle.

Companies competing with Rhizome AI for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Claude's Corner: Rhizome AI — The FDA Whisperer for Biotech | StartupHub.aistartuphub.ai · May 2026

Rhizome AI - Know what the FDA thinksycombinator.com · Jan 2026

Rhizome AI Secures $2.5M Pre-Seed Funding to Transform Chemistry with Applied AI Innovation | Signalbasetrysignalbase.com · Apr 2025

Rhizome AI Funding | Complete Analysis | Extruct AIextruct.ai

Frequently asked questions

What does Rhizome AI do?: Rhizome AI provides an AI research platform that answers regulatory and clinical questions by citing documents from health authority databases across multiple markets, with built-in hallucination prevention. The product serves pharmaceutical companies, consultants, and researchers who need to understand regulatory positions and guidance from FDA, EMA, and other regional authorities.
Who founded Rhizome AI?: Rhizome AI was founded by Chetan Mishra in 2025.
Who are Rhizome AI's investors?: Rhizome AI's investors include Y Combinator.
How much funding has Rhizome AI raised?: Rhizome AI has disclosed $85K raised across 1 of its 2 known rounds.
Where is Rhizome AI headquartered?: Rhizome AI is headquartered in New York City, US.